CAS 130120-57-9PubChem CID 9876021
Prezatide Copper Acetate
- IUPAC name
- copper;acetic acid;bis((2S)-6-amino-2-[[(2S)-2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoate)
- Molecular formula
- C32H54CuN12O12
- Molecular weight
- 862.4 g/mol
- Exact mass
- 861.328012 Da
- Topological polar surface area
- 433.0 Ų
- Hydrogen-bond donors
- 12
- Hydrogen-bond acceptors
- 18
- Covalent units
- 5
- Defined stereocentres
- 4
Also known as
IaminPC1020 acetateBIS(TRIPEPTIDE-1) COPPER ACETATEA3LEI4P1NBPC-1020 ACETATEPC-1020prezatidi cuprici acetasRefChem:175996
2 more reported names
acetate de prezatide cupriqueacetato de prezatida de cobre
Evidence from additional scientific databases
NIH PubChem PUG-View
Exact identifier match9876021
Attributed physical-property, hazard, environmental and use annotations.
- GHS Hazard Statements: Not Classified; Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
- Cosmetic Ingredient Review Finding(s): Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org Source: Cosmetic Ingredient Review (CIR)
- Cosmetic Ingredient Review Link: CIR ingredient: Bis(Tripeptide-1) Copper Acetate Source: Cosmetic Ingredient Review (CIR)
Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record
Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.
Additional source coverage and match status
| Source | Result | Checked |
|---|---|---|
| NIH PubChem PUG-View | Exact match | 2026-08-31 |
A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.